Mirova’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-1,249
| Closed | -$227K | – | 124 |
|
2024
Q1 | $227K | Hold |
1,249
| – | – | 0.04% | 104 |
|
2023
Q4 | $194K | Sell |
1,249
-76
| -6% | -$11.8K | 0.04% | 85 |
|
2023
Q3 | $198K | Sell |
1,325
-3,499
| -73% | -$522K | 0.04% | 88 |
|
2023
Q2 | $650K | Sell |
4,824
-5,963
| -55% | -$803K | 0.11% | 79 |
|
2023
Q1 | $1.72M | Sell |
10,787
-229
| -2% | -$36.5K | 0.25% | 68 |
|
2022
Q4 | $1.78M | Buy |
11,016
+1,155
| +12% | +$187K | 0.28% | 72 |
|
2022
Q3 | $1.32M | Sell |
9,861
-1,500
| -13% | -$201K | 0.22% | 76 |
|
2022
Q2 | $1.74M | Buy |
11,361
+753
| +7% | +$115K | 0.25% | 68 |
|
2022
Q1 | $1.72M | Sell |
10,608
-175
| -2% | -$28.4K | 0.23% | 60 |
|
2021
Q4 | $1.46M | Buy |
10,783
+4,831
| +81% | +$654K | 0.17% | 70 |
|
2021
Q3 | $642K | Buy |
5,952
+525
| +10% | +$56.6K | 0.08% | 106 |
|
2021
Q2 | $611K | Hold |
5,427
| – | – | 0.07% | 97 |
|
2021
Q1 | $587K | Buy |
5,427
+876
| +19% | +$94.8K | 0.07% | 94 |
|
2020
Q4 | $487K | Buy |
4,551
+3,219
| +242% | +$344K | 0.06% | 91 |
|
2020
Q3 | $117K | Sell |
1,332
-317
| -19% | -$27.8K | 0.02% | 88 |
|
2020
Q2 | $162K | Sell |
1,649
-6
| -0.4% | -$589 | 0.04% | 66 |
|
2020
Q1 | $126K | Sell |
1,655
-788
| -32% | -$60K | 0.05% | 73 |
|
2019
Q4 | $216K | Buy |
2,443
+760
| +45% | +$67.2K | 0.08% | 77 |
|
2019
Q3 | $127K | Buy |
1,683
+152
| +10% | +$11.5K | 0.02% | 85 |
|
2019
Q2 | $111K | Hold |
1,531
| – | – | 0.01% | 87 |
|
2019
Q1 | $123K | Buy |
1,531
+456
| +42% | +$36.6K | 0.07% | 68 |
|
2018
Q4 | $99K | Buy |
+1,075
| New | +$99K | 0.05% | 69 |
|